This week's edition of Life Sciences weekly highlights includes two news analyses on the EU AI Act, its key developments and strategic implications for business as well as the challenges of the EU AI Act-GDPR interplay, and news that the European Commission opened a targeted consultation on guidelines to clarify rules for general-purpose artificial intelligence (GPAI) models under the EU AI Act, the Association of British HealthTech Industries (ABHI) published guidance to help UK policymakers considering international regulatory reform and recognition understand the US Food and Drug Administration (FDA) 510(k) process of pre-market submission for devices deemed substantially equivalent to those already legally marketed, the EFPIA released a research on assessment of the impact of the transferable exclusivity voucher (TEV) system proposed as part of the pharmaceutical legislation reform package, both the EFPIA and MedTech Europe have submitted responses to the Commission’s call for evidence on the EU Life Sciences Strategy. Also included is news that the MHRA issued new guidance on risk minimisation measures...
To continue reading this news article, as well as thousands of others like it, sign in with ÀÏ˾»úÎçÒ¹¸£Àû or register for a free trial
EXISTING USER? SIGN IN CONTINUE READING GET A QUOTE
To read the full news article, register for a free Lexis+ trial
**Trials are provided to all ÀÏ˾»úÎçÒ¹¸£Àû content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these ÀÏ˾»úÎçÒ¹¸£Àû services please email customer service via our online form. Free trials are only available to individuals based in the UK, Ireland and selected UK overseas territories and Caribbean countries. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
* denotes a required field
Micklefield clausesWhat is a Micklefield clause?It is common for employee share plans to provide that, on termination of employment (or when an employee is given or receives notice of termination of employment), subsisting share awards will be forfeited and subsisting share options will lapse.It is
Late payment penalties—inheritance taxWhile interest often accrues on overdue tax, the late payment of certain taxes may also attract a penalty. For information on the interest accruing on overdue tax, see Practice Notes: IHT—payment deadlines on death—Interest on IHT and Interest on late paid
Brussels I (recast)—domicile (Arts 4 and 63) [Archived]ARCHIVED: This Practice Note has been archived and is not maintained.This Practice Note considers the general rule set out in Article 4 of Regulation (EU) 1215/2012, Brussels I (recast) when determining the relevance of a defendant’s domicile to
Contributory negligence in personal injury claimsContributory negligence is a partial defence which can lead to a discount in damages.Other defences may also be relevant. See Practice Notes: Did the claimant consent to the risk of injury? and Was the claimant involved in an illegal activity?If a
0330 161 1234